SEARCH

Press Releases

  • Connie Ryan announces retirement from Streck
    Connie Ryan announces retirement from Streck La Vista, Nebraska – After 42 years of dedicated service, Connie Ryan has announced her retirement from Streck. Since joining the company in 1982, Connie has been instrumental in shaping Streck into the industry leader for quality controls and …
  • Streck to distribute Ceres NEAT Liquid Biopsy Kit – Streck BCT worldwide
    Streck to distribute Ceres NEAT Liquid Biopsy Kit – Streck BCT worldwide La Vista, Nebraska – Streck is pleased to announce an expanded partnership with Ceres Nanosciences (Ceres) to distribute the Nanotrap® Extraction Advanced Technology (NEAT) Liquid Biopsy Kit – Streck BCT worldwide. The NEAT …
  • Streck establishes partnership with Longhorn Vaccines and Diagnostics to distribute PrimeStore® MTM worldwide
    Streck establishes partnership with Longhorn Vaccines and Diagnostics to distribute PrimeStore® MTM worldwide La Vista, Nebraska – Streck is pleased to announce its new partnership with Longhorn Vaccines and Diagnostics to distribute its flagship product, PrimeStore® Molecular Transport Media (MTM), worldwide. PrimeStore® MTM is an …
  • Streck Announces Partnership with Longhorn Vaccines and Diagnostics
    Streck Announces Partnership with Longhorn Vaccines and Diagnostics La Vista, Nebraska – Streck is pleased to announce its new distribution partnership with Longhorn Vaccines and Diagnostics. The partnership is a natural fit for both companies, as they both focus on providing laboratories with stabilization solutions …
  • Streck launches Protein Plus BCT for stabilization of plasma proteins in whole blood
      Streck launches Protein Plus BCT for stabilization of plasma proteins in whole blood   La Vista, Nebraska – Streck is pleased to announce the launch of Protein Plus BCTTM, a direct draw whole blood collection tube intended for the stabilization of draw-time concentrations of …
  • MDx-Chex for BC-GP and BC-GN Launch
    MDx-Chex® for BC-GP and BC-GN, new full-process, molecular diagnostics quality controls for bloodstream infections, receive FDA clearance La Vista, Nebraska – Streck is pleased to announce that MDx-Chex® for BC-GP and MDx-Chex® for BC-GN, quality controls designed to verify the performance of the Luminex® VERIGENE® …
  • Streck Announces Series B Investment in Ceres Nanosciences
    Streck Announces Series B Investment in Ceres Nanosciences La Vista, Nebraska – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The funds from this investment will be used to accelerate the development and commercialization of both diagnostic and research use products utilizing …
  • Streck introduces viral extraction kit for clinical samples
    Streck introduces viral extraction kit for clinical samples La Vista, NE – Streck is pleased to announce the commercialization of Streck® Viral Extraction Kit with partner Ceres Nanosciences. Streck has developed a viral extraction kit utilizing Nanotrap® technology to shorten hands-on time and simplify the …
  • Streck’s first-of-its-kind molecular diagnostics quality control MDx-Chex for BCID2 receives FDA clearance
    Streck’s first-of-its-kind molecular diagnostics quality control MDx-Chex for BCID2 receives FDA clearance La Vista, NE –Streck is pleased to announce MDx-Chex™ for BCID2, a first-of-its-kind quality control designed to meet the standards for verifying the performance of the BioFire® BCID2 Panel for sepsis, has been …
  • Streck establishes partnership with Ceres Nanosciences to distribute COVID-19 wastewater surveillance solution
    Streck establishes partnership with Ceres Nanosciences to distribute COVID-19 wastewater surveillance solution La Vista, NE –Streck is pleased to announce the partnership with Ceres Nanosciences to distribute Nanotrap® Magnetic Virus Particles that provide rapid viral concentration directly from raw sewage. This product dramatically reduces the …
  • Streck launches first-of-its-kind molecular quality control MDx-Chex for BCID2
    Streck is pleased to announce MDx-Chex™ for BCID2, a first-of-its-kind quality control designed to meet the standards for verifying the performance of sample-to-result molecular tests for sepsis. MDx-Chex for BCID2 is For Research Use Only. Not for use in diagnostic procedures.
  • Streck Cell-Free DNA BCT receives U.S. FDA De Novo clearance
    Streck Cell-Free DNA BCT received U.S. Food and Drug Administration De Novo clearance for In Vitro Diagnostic use when paired with the Guardant360 CDx liquid biopsy assay. Cell-Free DNA BCT is the first and only circulating nucleic acid blood collection tube to be cleared for use with liquid biopsy.
  • Biodesix Partners with Streck to Support In Vitro Diagnostic (IVD) Strategy
    Biodesix, Inc. and Streck, Inc. today announced a Regulatory Cooperation Agreement that will further enable both companies in their pursuit of FDA approval for diagnostic testing services and specimen collection products.